Skip to main content

Advertisement

Log in

Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab

  • Case Report
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To report a case of familial exudative vitreoretinopathy (FEVR) rapidly resolved by intravitreal injection of bevacizumab.

Methods

A 36-year-old woman complained about floaters and visual field defect. Funduscopic examinations revealed retinal vessel anastomosis located between the equator and ora serrata in both eyes. The right eye was accompanied with slight vitreous hemorrhage. Since the patient declined retinal cryopexy for cosmetic reasons, intravitreal bevacizumab injections (1.25 mg/0.05 ml) were performed in both eyes.

Results

Treatment resulted in the rapid regression and the accelerated fibrosis of neovascular tissues. At 4-month follow-up in the right eye and 1-month follow-up in the left, no signs of systemic or ocular complications were detected.

Conclusions

Intravitreal injection of bevacizumab may be considered as an alternative method in treating FEVR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Criswick VG, Schepens CL (1969) Familial exudative vitreoretinopathy. Am J Ophthalmol 68:578–594

    PubMed  CAS  Google Scholar 

  2. van Nouhuys CE (1989) Juvenile retinal detachment as a complicaton of familial exudative vitreoretinopathy. Fortschr Ophthalmol 86:221–223

    PubMed  Google Scholar 

  3. Mintz-Hittner HA, Kuffel RR Jr (2008) Intravitreal bevacizumab(Avastin) treatment of stage 3 retinopathy of prematurity in zone Ior posterior zone II. Retina 28(6):831–838, doi:10.1097/IAE.0b013e318177f934

    Article  PubMed  Google Scholar 

  4. Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN (2006) Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 142:1–9, doi:10.1016/j.ajo.2006.02.037

    Article  PubMed  CAS  Google Scholar 

  5. Iturralde D, Spaide RF, Meyerle CB (2006) Intravitreal bevacizumab(Avastin) treatment of macula edema in central retinal vein occulusion: a short-term study. Retina 26:279–284, doi:10.1097/00006982-200603000-00005

    Article  PubMed  Google Scholar 

  6. Spaide RF, Fisher YL (2006) Intravitreal bevacizumab(Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26:275–278, doi:10.1097/00006982-200603000-00004

    Article  PubMed  Google Scholar 

  7. Honda S, Hirabayashi H, Tsukahara Y et al (2008) Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246(7):1061–1063, doi:10.1007/s00417-008-0786-7

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shigeru Honda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tagami, M., Kusuhara, S., Honda, S. et al. Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 246, 1787–1789 (2008). https://doi.org/10.1007/s00417-008-0949-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-008-0949-6

Keywords

Navigation